Why Mira Pharmaceuticals Stock Is Moving Higher Monday
Why Mira Pharmaceuticals Stock Is Moving Higher Monday
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares are trading higher after the company said testing has confirmed its preliminary beliefs regarding a new potential treatment for neurological and neuropsychiatric disorders.
MIRA Pharmaceuticals, Inc.（納斯達克股票代碼：MIRA）股價走高，此前該公司表示，測試已證實了其對神經系統和神經精神疾病潛在新療法的初步看法。
The Details: The company is currently evaluating a pharmaceutical drug, MIRA-55, as a possible treatment for anxiety and cognitive decline.
詳情：該公司目前正在評估一種名爲 MIRA-55 的藥物作爲治療焦慮和認知能力下降的可能方法。
Preclinical tests showed promising results including stronger efficacy when compared to THC. Different dosage levels of THC may weaken its effectiveness, however, MIRA-55 maintained its efficacy across dosage levels.
臨床前測試顯示出令人鼓舞的結果，包括與四氫大麻酚相比更強的療效。不同劑量水平的四氫大麻酚可能會削弱其有效性，但是，MIRA-55 在不同劑量水平上保持其功效。
In addition, the novel drug outperformed THC in reducing anxiety driven behaviors and demonstrated a promising safety profile, potentially safer for human therapeutic use.
此外，這種新藥在減少焦慮行爲方面的表現優於四氫大麻酚，並且表現出令人鼓舞的安全性，可能更安全地用於人體治療。
"Our dedication to developing innovative treatments continues to drive our research and development efforts. We will be conducting additional preclinical studies to advance us closer to an Investigational New Drug (IND) application for MIRA-55," said Erez Aminov, CEO and chairman of Mira Pharmaceuticals.
“我們致力於開發創新療法，繼續推動我們的研發工作。我們將進行更多的臨床前研究，以推動我們更接近於 MIRA-55 的研究性新藥（IND）申請。” Mira Pharmicals首席執行官兼董事長埃雷茲·阿米諾夫說。
Related Link: Analyst Expectations For Sage Therapeutics's Future
相關鏈接：分析師對Sage Therapeutics未來的預期
MIRA Price Action: MIRA Pharmaceuticals stock is trading 30.5% higher at 76 cents at the time of publication per data from Benzinga Pro.
MIRA價格走勢：根據Benzinga Pro的數據，截至發佈時，MIRA製藥股價上漲30.5％，至76美分。
Image: 1569173 from Pixabay.
圖片：來自 Pixabay 的 1569173。